
|Videos|November 19, 2018
Rationale for Genetic Testing in Patients With DLBCL
Author(s)Julie M. Vose, MD, MBA
Julie M. Vose, MD, MBA, discusses the importance of conducting genetic testing on all patients with diffuse large B-cell lymphoma to better understand their disease and treat the disease properly.
Advertisement
Julie M. Vose, MD, MBA, professor of internal medicine and chief of the division of oncology & hematology at the University of Nebraska Medical Center, discusses the importance of conducting genetic testing on all patients with diffuse large B-cell lymphoma (DLBCL) to better understand their disease and treat the disease properly.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5








































